Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inhaled Medications01:23

Inhaled Medications

237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

233
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
233
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted self-directed learning can support clinicians to improve patient adherence to inhaled corticosteroid therapy in asthma.

BMJ open respiratory research·2025
Same author

Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumab.

Immunotherapy·2025
Same author

Clinical Accuracy and Risk of Harm in Asthma-Related Content on TikTok.

Chest·2024
Same author

Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.

The journal of allergy and clinical immunology. In practice·2024
Same author

The role of the clinical pharmacist in the respiratory or sleep multidisciplinary team.

Breathe (Sheffield, England)·2023
Same author

Diagnosing and managing pleural disease.

Breathe (Sheffield, England)·2023

相关实验视频

Updated: Jun 5, 2025

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K

在严重的喘中,吸入器粘附是否真的很重要?

Gráinne d'Ancona1,2, Brian D Kent3,4

  • 1Guy's and St Thomas' NHS Foundation Trust, London, UK.

Breathe (Sheffield, England)
|December 11, 2024
PubMed
概括

吸入性皮质类固醇 (ICS) 是标准的喘治疗方法,但一些严重的喘患者表现出耐药性. 本综述质疑要求那些对这种治疗没有反应的人遵守ICS.

科学领域:

  • 肺部病理学 肺部病理学
  • 呼吸系统医学 呼吸系统医学
  • 临床治疗学 临床治疗学

背景情况:

  • 自20世纪60年代以来,吸入性皮质类固醇 (ICS) 已成为喘的主要治疗方法.
  • ICS疗法有效地减少了喘症状,并发症和死亡率.
  • 尽管使用ICS,但有一部分患者表现出严重的,不受控制的喘.

研究的目的:

  • 审查要求坚持吸入性皮质类固醇 (ICS) 治疗的有效性和适当性.
  • 为了检查严重喘患者的治疗耐药性.
  • 讨论治疗严重的ICS耐性喘的替代方法.

主要方法:

  • 对吸入性皮质类固醇 (ICS) 在喘中的疗效研究的文献综述.
  • 对严重喘定义和治疗坚持挑战的分析.
  • 关于特定患者队列中ICS耐药性的临床证据的讨论.

主要成果:

  • 高剂量的ICS疗法对于所有严重喘患者来说并不普遍有效.
  • 一大批严重喘患者表现出对ICS治疗的耐药性.
  • 目前的坚持要求可能不适合ICS耐药的个体.

更多相关视频

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K

相关实验视频

Last Updated: Jun 5, 2025

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K

结论:

  • 吸入性皮质类固醇 (ICS) 治疗的有效性在严重喘患者之间有所不同.
  • 在对ICS耐药的严重喘队伍中,应对治疗的坚持进行批判性评估.
  • 对抗ICS严重喘的替代疗法的进一步研究是有必要的.